Monitor future filings for disclosure of the size of the Onconetix investment and any material financial impact from the portfolio liquidation. The Realbotix acquisition by Onconetix may be a catalyst if it closes, but SRX's stake is undisclosed.
Price Chart
Executive Summary
SRX Global announced the liquidation of its holdings in Vistagen Therapeutics and Greenland Mines, and a new investment in Onconetix Inc., which has an agreement to acquire Realbotix LLC, a robotics company with proprietary AI vision technology. The portfolio repositioning is a routine capital allocation update with no disclosed financial terms, making it a neutral event.
Key Facts
- SRX Global liquidated its portfolio holdings in Vistagen Therapeutics (Nasdaq: VTGN) and Greenland Mines (Nasdaq: GRML).
- SRX Global added an investment in Onconetix Inc. (Nasdaq: ONCO).
- Onconetix has an agreement to acquire Realbotix LLC, which uses proprietary robotic eyeball technology and the Vinci AI Vision System.
- No financial terms (dollar amounts, share counts, proceeds, or investment size) were disclosed for any of the transactions.
Financial Impact
No financial figures disclosed for liquidation proceeds or new investment amount.
Risk Factors
- Lack of disclosed financial terms makes it impossible to assess the materiality of the portfolio changes.
- The Onconetix-Realbotix acquisition is pending and subject to closing conditions; failure to close could impair the investment's value.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3368634 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | 8-K | $1.49 $1.29 | ▼ −13.42% | ▼ −12.44% | $1.03 (−30.54%) |
Oct 6, 2026 20d ago | 8-K | $1.49 $1.29 | ▼ −13.42% | ▼ −12.44% | $1.03 (−30.54%) |
Sep 24, 2026 4w ago | Press Release | $1.73 $1.61 | ▼ −6.94% | ▼ −6.52% | $1.03 (−40.17%) |
Sep 9, 2026 6w ago | 8-K | $1.51 $1.60 | ▲ +5.96% | ▲ +6.62% | $1.03 (−31.46%) |
Sep 2, 2026 7w ago | 8-K | $1.56 $1.59 | ▲ +1.92% | ▲ +3.07% | $1.03 (−33.65%) |
Aug 28, 2026 8w ago | 8-K | $1.68 $1.59 | ▲ +5.65% | ▲ +5.51% | $1.03 (+38.39%) |
Aug 19, 2026 9w ago | 8-K | $1.87 $1.84 | ▼ −1.60% | ▼ −1.22% | $1.03 (−44.65%) |
Aug 4, 2026 12w ago | Press Release | $1.37 $1.84 | ▲ +34.31% | ▲ +34.41% | $1.03 (−24.45%) |
Aug 3, 2026 12w ago | Press Release | $1.44 $1.73 | ▲ +20.14% | ▲ +18.11% | $1.03 (−28.13%) |
Jul 30, 2026 12w ago | Press Release | $1.48 $1.43 | ▼ −3.38% | ▼ −7.00% | $1.03 (−30.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers